Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
12.67B | 12.34B | 12.65B | 12.40B | 10.12B | Gross Profit |
4.02B | 3.86B | 3.83B | 3.67B | 2.81B | EBIT |
621.00M | 615.00M | 747.00M | 851.66M | 535.30M | EBITDA |
941.00M | 877.00M | 1.09B | 1.07B | 726.81M | Net Income Common Stockholders |
390.00M | 416.00M | 538.00M | 631.00M | 403.79M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
122.00M | 171.00M | 117.00M | 117.97M | 421.19M | Total Assets |
10.22B | 10.57B | 8.61B | 8.48B | 7.77B | Total Debt |
2.87B | 2.74B | 1.50B | 1.22B | 1.00B | Net Debt |
2.75B | 2.57B | 1.38B | 1.10B | 581.23M | Total Liabilities |
5.38B | 5.42B | 3.94B | 4.42B | 3.79B | Stockholders Equity |
3.39B | 3.65B | 3.45B | 3.43B | 3.35B |
Cash Flow | Free Cash Flow | |||
661.00M | 313.00M | 506.00M | 630.57M | 550.08M | Operating Cash Flow |
848.00M | 500.00M | 602.00M | 709.58M | 598.91M | Investing Cash Flow |
-430.00M | -1.14B | -276.00M | -677.22M | -115.02M | Financing Cash Flow |
-510.00M | 701.00M | -315.00M | -332.96M | -187.19M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $56.51B | 33.84 | 161.58% | 0.74% | 12.18% | -5.92% | |
76 Outperform | $90.30B | 28.06 | 51.23% | 0.38% | 16.22% | 15.29% | |
74 Outperform | $8.59B | 21.88 | 11.78% | ― | 1.75% | 8.76% | |
68 Neutral | $37.05B | 24.24 | -43.80% | 1.30% | 0.78% | 183.45% | |
53 Neutral | $5.25B | 3.24 | -45.38% | 2.81% | 16.79% | -0.06% | |
44 Neutral | $486.50M | ― | -49.91% | ― | 2.84% | -828.91% |
On May 22, 2025, Henry Schein, Inc. held its 2025 Annual Meeting of Stockholders where key proposals were approved, including the election of twelve directors for terms expiring in 2026, and the election of Max Lin and William K. ‘Dan’ Daniel as directors. The meeting also saw the approval of the 2024 compensation for Named Executive Officers and the ratification of BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending December 27, 2025. These decisions are expected to impact the company’s governance and financial oversight positively.
The most recent analyst rating on (HSIC) stock is a Buy with a $75.00 price target. To see the full list of analyst forecasts on Henry Schein stock, see the HSIC Stock Forecast page.
On May 16, 2025, Henry Schein, Inc. completed a $250 million strategic investment deal with KKR, making KKR the holder of approximately 12% of Henry Schein’s common shares. This investment is part of a strategic partnership agreement that also led to the appointment of William K. ‘Dan’ Daniel to Henry Schein’s Board of Directors. Daniel, an Executive Advisor at KKR, brings over three decades of leadership experience in the industrial and healthcare sectors. His appointment, alongside Max Lin from KKR, is expected to support Henry Schein’s strategic growth and long-term value creation for stakeholders.
The most recent analyst rating on (HSIC) stock is a Buy with a $75.00 price target. To see the full list of analyst forecasts on Henry Schein stock, see the HSIC Stock Forecast page.
On May 2, 2025, Henry Schein, Inc. and KKR Hawaii Aggregator L.P. entered into a letter agreement to remove KKR’s voting commitment from their Strategic Partnership Agreement, while maintaining all other terms. Additionally, Max Lin was appointed to Henry Schein’s board of directors as an independent director, following the satisfaction of regulatory conditions. Lin, a partner at KKR, will serve on the Nominating and Governance Committee and the Strategic Advisory Committee, bringing extensive experience from his roles in healthcare and private equity.
On April 10, 2025, Henry Schein, Inc. announced the adoption of an Executive Severance Plan and an amended Executive Change in Control Plan. These plans are designed to provide severance benefits to certain executive-level employees under specific circumstances, such as termination without cause or resignation for good reason. The plans include provisions for base salary continuation, pro-rated bonuses, and other benefits, while incorporating restrictive covenants and clawback policies to protect the company’s interests.
On March 11, 2025, Henry Schein, Inc. announced that James P. Breslawski, the company’s President, will transition from his role effective April 1, 2025. He will take on a new position as Senior Advisor while remaining on the Executive Management Committee, signaling a strategic shift in leadership roles within the company.